FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362488804> ?p ?o ?g. }

• W4362488804 abstract "<div>Abstract<p>Targeting the programmed death 1/programmed death ligand 1 (PD-1/PD-L1) pathway with immunotherapy has revolutionized the treatment of many cancers. Somatic tumor mutational burden (TMB) and T-cell–inflamed gene expression profile (GEP) are clinically validated pan-tumor genomic biomarkers that can predict responsiveness to anti-PD-1/PD-L1 monotherapy in many tumor types. We analyzed the association between these biomarkers and the efficacy of PD-1 inhibitor in 11 commonly used preclinical syngeneic tumor mouse models using murinized rat anti-mouse PD-1 DX400 antibody muDX400, a surrogate for pembrolizumab. Response to muDX400 treatment was broadly classified into three categories: highly responsive, partially responsive, and intrinsically resistant to therapy. Molecular and cellular profiling validated differences in immune cell infiltration and activation in the tumor microenvironment of muDX400-responsive tumors. Baseline and on-treatment genomic analysis showed an association between TMB, murine T-cell–inflamed gene expression profile (murine-GEP), and response to muDX400 treatment. We extended our analysis to investigate a canonical set of cancer and immune biology-related gene signatures, including signatures of angiogenesis, myeloid-derived suppressor cells, and stromal/epithelial-to-mesenchymal transition/TGFβ biology previously shown to be inversely associated with the clinical efficacy of immune checkpoint blockade. Finally, we evaluated the association between murine-GEP and preclinical efficacy with standard-of-care chemotherapy or antiangiogenic agents that previously demonstrated promising clinical activity, in combination with muDX400. Our profiling studies begin to elucidate the underlying biological mechanisms of response and resistance to PD-1/PD-L1 blockade represented by these models, thereby providing insight into which models are most appropriate for the evaluation of orthogonal combination strategies.</p></div>" @default.
• W4362488804 created "2023-04-05" @default.
• W4362488804 creator A5001519803 @default.
• W4362488804 creator A5005029294 @default.
• W4362488804 creator A5011197905 @default.
• W4362488804 creator A5012710993 @default.
• W4362488804 creator A5016739528 @default.
• W4362488804 creator A5018151367 @default.
• W4362488804 creator A5019898638 @default.
• W4362488804 creator A5025122340 @default.
• W4362488804 creator A5026798889 @default.
• W4362488804 creator A5027285428 @default.
• W4362488804 creator A5033635354 @default.
• W4362488804 creator A5037015805 @default.
• W4362488804 creator A5041237312 @default.
• W4362488804 creator A5042693679 @default.
• W4362488804 creator A5048640117 @default.
• W4362488804 creator A5048740840 @default.
• W4362488804 creator A5048759682 @default.
• W4362488804 creator A5051844715 @default.
• W4362488804 creator A5053855652 @default.
• W4362488804 creator A5054654521 @default.
• W4362488804 creator A5060841115 @default.
• W4362488804 creator A5063447892 @default.
• W4362488804 creator A5065172378 @default.
• W4362488804 creator A5065424404 @default.
• W4362488804 creator A5067520628 @default.
• W4362488804 creator A5073760159 @default.
• W4362488804 creator A5073783446 @default.
• W4362488804 creator A5081354184 @default.
• W4362488804 creator A5082665065 @default.
• W4362488804 date "2023-04-03" @default.
• W4362488804 modified "2023-10-15" @default.
• W4362488804 title "Data from Reverse Translating Molecular Determinants of Anti–Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models" @default.
• W4362488804 doi "https://doi.org/10.1158/1535-7163.c.6543385" @default.
• W4362488804 hasPublicationYear "2023" @default.
• W4362488804 type Work @default.
• W4362488804 citedByCount "0" @default.
• W4362488804 crossrefType "posted-content" @default.
• W4362488804 hasAuthorship W4362488804A5001519803 @default.
• W4362488804 hasAuthorship W4362488804A5005029294 @default.
• W4362488804 hasAuthorship W4362488804A5011197905 @default.
• W4362488804 hasAuthorship W4362488804A5012710993 @default.
• W4362488804 hasAuthorship W4362488804A5016739528 @default.
• W4362488804 hasAuthorship W4362488804A5018151367 @default.
• W4362488804 hasAuthorship W4362488804A5019898638 @default.
• W4362488804 hasAuthorship W4362488804A5025122340 @default.
• W4362488804 hasAuthorship W4362488804A5026798889 @default.
• W4362488804 hasAuthorship W4362488804A5027285428 @default.
• W4362488804 hasAuthorship W4362488804A5033635354 @default.
• W4362488804 hasAuthorship W4362488804A5037015805 @default.
• W4362488804 hasAuthorship W4362488804A5041237312 @default.
• W4362488804 hasAuthorship W4362488804A5042693679 @default.
• W4362488804 hasAuthorship W4362488804A5048640117 @default.
• W4362488804 hasAuthorship W4362488804A5048740840 @default.
• W4362488804 hasAuthorship W4362488804A5048759682 @default.
• W4362488804 hasAuthorship W4362488804A5051844715 @default.
• W4362488804 hasAuthorship W4362488804A5053855652 @default.
• W4362488804 hasAuthorship W4362488804A5054654521 @default.
• W4362488804 hasAuthorship W4362488804A5060841115 @default.
• W4362488804 hasAuthorship W4362488804A5063447892 @default.
• W4362488804 hasAuthorship W4362488804A5065172378 @default.
• W4362488804 hasAuthorship W4362488804A5065424404 @default.
• W4362488804 hasAuthorship W4362488804A5067520628 @default.
• W4362488804 hasAuthorship W4362488804A5073760159 @default.
• W4362488804 hasAuthorship W4362488804A5073783446 @default.
• W4362488804 hasAuthorship W4362488804A5081354184 @default.
• W4362488804 hasAuthorship W4362488804A5082665065 @default.
• W4362488804 hasConcept C126322002 @default.
• W4362488804 hasConcept C16930146 @default.
• W4362488804 hasConcept C170493617 @default.
• W4362488804 hasConcept C203014093 @default.
• W4362488804 hasConcept C2776107976 @default.
• W4362488804 hasConcept C2777701055 @default.
• W4362488804 hasConcept C2778468042 @default.
• W4362488804 hasConcept C2780057760 @default.
• W4362488804 hasConcept C2780674031 @default.
• W4362488804 hasConcept C2780851360 @default.
• W4362488804 hasConcept C2781053074 @default.
• W4362488804 hasConcept C502942594 @default.
• W4362488804 hasConcept C71924100 @default.
• W4362488804 hasConcept C86803240 @default.
• W4362488804 hasConcept C8891405 @default.
• W4362488804 hasConceptScore W4362488804C126322002 @default.
• W4362488804 hasConceptScore W4362488804C16930146 @default.
• W4362488804 hasConceptScore W4362488804C170493617 @default.
• W4362488804 hasConceptScore W4362488804C203014093 @default.
• W4362488804 hasConceptScore W4362488804C2776107976 @default.
• W4362488804 hasConceptScore W4362488804C2777701055 @default.
• W4362488804 hasConceptScore W4362488804C2778468042 @default.
• W4362488804 hasConceptScore W4362488804C2780057760 @default.
• W4362488804 hasConceptScore W4362488804C2780674031 @default.
• W4362488804 hasConceptScore W4362488804C2780851360 @default.
• W4362488804 hasConceptScore W4362488804C2781053074 @default.
• W4362488804 hasConceptScore W4362488804C502942594 @default.
• W4362488804 hasConceptScore W4362488804C71924100 @default.
• W4362488804 hasConceptScore W4362488804C86803240 @default.
• W4362488804 hasConceptScore W4362488804C8891405 @default.
• W4362488804 hasLocation W43624888041 @default.
• W4362488804 hasOpenAccess W4362488804 @default.

• next